WINSTON-SALEM, N.C. — The Winston-Salem Police Department is asking for the public's help locating a 12-year-old who went ...

Although as of this week the stock has declined by more than 4% since the start of the year, there's little reason to believe ...

The deal prepares for a pain treatment market rivalry with Vertex Pharmaceuticals as the industry starts to move away from ...

Elevate your golf game with this Lilly Pulitzer matching set, featuring a UPF 50 jacket and skort in a fun pink gingham print for effortless style on the course. Add a touch of coastal charm to ...

The acquisition expands Lilly’s pain pipeline with a slate of drugs targeting ion channel proteins like NaV1.7 and NaV1.8.

If you wait for a top growth stock to come down to a P/E of 20 or less, you may end up waiting forever and missing out on the opportunity completely. For years, Eli Lilly has been generating solid ...

This was the stock's second consecutive day of gains.

Revenue and net income reported in billions We expect Lilly’s P/E ratio in 2025 to be 60 with an EPS of $19.11, resulting in a price target of $1,140.00. This prediction is based on strong ...